Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Pain Control Following Mastectomy
NCT03722927Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Wake Forest University Health Sciences. Started Jun 2018; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03722927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722927.